Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / memo-indemnification-analysis.docx
memo-indemnification-analysis.docx
Parties
Harkness LLP
Caldwell LLP
M. Castañeda
Dates
February 10, 2026
February 7, 2026
January 28, 2026
February 12, 2026
April 7, 2026
June 30, 2029
December 18, 2025
November 22, 2025
January 15, 2026
February 18, 2026
Amounts
$6,000,000
$10,000,000
$15,000,000
$74
$25,000,000
$250,000
$5,000,000
Obligations
Notice Period for Claims — the time frame within which HUMC must notify TMRI of claims or threatened claims triggering indemnification; 4
This date is driven by TMRI's need to include the fully executed CTA as part of its IDE supplement filing with the FDA, which must be submitted by March 15, 2026, to avoid delays to the Cobalt Ridge Health IT-3 enrollment timeline
This dual exposure is a central factor in the indemnification negotiation, as it means that TMRI cannot credibly disclaim responsibility for the safety characteristics of the device and must accept some level of device-related indemnification beyond narrow defect claims
TMRI's rationale for aligning the cap with the per-occurrence limit is straightforward: as a nonprofit research institution with finite financial resources, TMRI must limit its contractual indemnification exposure to amounts that are fully insured
Large teaching hospitals and research institutions typically have multi-tiered risk management structures in which potential claims must be identified, evaluated, and escalated through several departments before a formal notice of claim is issued to a contractual indemnitor
We therefore recommend that TMRI accommodate HUMC's request for conflict-of-interest participation rights, subject to the following guardrails designed to prevent abuse and manage costs: (a) The conflict of interest must be actual, not merely theoretical or speculative